Gut microbiota induce IGF-1 and promote bone formation and growth

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 47, 2016, Pages E7554-E7563

  Yan, Jing ^a   Herzog, Jeremy W ^b   Tsang, Kelly ^a   Brennan, Caitlin A ^c   Bower, Maureen A ^b   Garrett, Wendy S ^c,d,e   Sartor, Balfour R ^b   Aliprantis, Antonios O ^a,f   Charles, Julia F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Bone; IGF 1; Microbiota; SCFA

Indexed keywords

AMPICILLIN; BACITRACIN; CIPROFLOXACIN; GENTAMICIN; METRONIDAZOLE; NEOMYCIN; SHORT CHAIN FATTY ACID; SOMATOMEDIN C; STREPTOMYCIN; VANCOMYCIN; INSULIN-LIKE GROWTH FACTOR-1, MOUSE; VOLATILE FATTY ACID;

ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; BACTERIAL COLONIZATION; BONE GROWTH; BONE MASS; BONE REMODELING; CONFERENCE PAPER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG ABSORPTION; FEMALE; GROWTH PLATE; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; INTESTINE FLORA; LIVER; MALE; MEDIATOR; MICROBIAL COLONIZATION; MICROBIAL METABOLISM; MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; RADIUS; SERUM; STIMULUS; ANIMAL; BONE; BONE DEVELOPMENT; GERMFREE ANIMAL; METABOLISM;

ADIPOSE TISSUE; ANIMALS; BONE AND BONES; BONE DEVELOPMENT; FATTY ACIDS, VOLATILE; FEMALE; GASTROINTESTINAL MICROBIOME; INSULIN-LIKE GROWTH FACTOR I; LIVER; MALE; MICE; OSTEOGENESIS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84996508337     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1607235113     Document Type: Article

References (64)

1. Bäckhed F, et al. (2012) Defining a healthy human gut microbiome: Current concepts, future directions, and clinical applications. Cell Host Microbe 12(5):611-622.
2. Clarke G, et al. (2014) Minireview: Gut microbiota: The neglected endocrine organ. Mol Endocrinol 28(8):1221-1238.
3. Yano JM, et al. (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161(2):264-276.
4. Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336(6086):1268-1273.
5. Nieuwdorp M, Gilijamse PW, Pai N, Kaplan LM (2014) Role of the microbiome in energy regulation and metabolism. Gastroenterology 146(6):1525-1533.
6. Bäckhed F, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101(44):15718-15723.
7. Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313-323.
8. Sharon G, et al. (2014) Specialized metabolites from the microbiome in health and disease. Cell Metab 20(5):719-730.
9. Smith PM, et al. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341(6145):569-573.
10. Arpaia N, et al. (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504(7480):451-455.
11. Furusawa Y, et al. (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446-450.
12. Singh N, et al. (2014) Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40(1):128-139.
13. Sjogren K, et al. (2012) The gut microbiota regulates bone mass in mice. J Bone Miner Res 27(6):1357-1367.
14. Schwarzer M, et al. (2016) Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science 351(6275):854-857.
15. Berendsen AD, Olsen BR (2015) Bone development. Bone 80:14-18.
16. Mackie EJ, Tatarczuch L, Mirams M (2011) The skeleton: A multi-functional complex organ: The growth plate chondrocyte and endochondral ossification. J Endocrinol 211(2):109-121.
17. Martes C, Karampouta E, Lazarides N (1975) [Indications for the use of saggittal splitting (based on 148 cases)]. Stomatologia (Athenai) 36(4):183-190.
18. Charles JF, Aliprantis AO (2014) Osteoclasts: More than 'bone eaters'. Trends Mol Med 20(8):449-459.
19. Charles JF, Ermann J, Aliprantis AO (2015) The intestinal microbiome and skeletal fitness: Connecting bugs and bones. Clin Immunol 159(2):163-169.
20. Cho I, et al. (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488(7413):621-626.
21. McCabe LR, Irwin R, Schaefer L, Britton RA (2013) Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol 228(8):1793-1798.
22. Britton RA, et al. (2014) Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol 229(11):1822-1830.
23. McCabe L, Britton RA, Parameswaran N (2015) Prebiotic and Probiotic Regulation of Bone Health: Role of the Intestine and its Microbiome. Curr Osteoporos Rep 13(6):363-371.
24. Zhang J, et al. (2015) Loss of Bone and Wnt10b Expression in Male Type 1 Diabetic Mice Is Blocked by the Probiotic Lactobacillus reuteri. Endocrinology 156(9):3169-3182.
25. Parvaneh K, Jamaluddin R, Karimi G, Erfani R (2014) Effect of probiotics supplementation on bone mineral content and bone mass density. Scientific World Journal 2014:595962.
26. Weaver CM (2015) Diet, gut microbiome, and bone health. Curr Osteoporos Rep 13(2):125-130.
27. Li JY, et al. (2016) Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest 126(6):2049-2063.
28. Hyun S (2013) Body size regulation and insulin-like growth factor signaling. Cell Mol Life Sci 70(13):2351-2365.
29. Erkosar B, Storelli G, Defaye A, Leulier F (2013) Host-intestinal microbiota mutualism: "learning on the fly". Cell Host Microbe 13(1):8-14.
30. Yakar S, Courtland HW, Clemmons D (2010) IGF-1 and bone: New discoveries from mouse models. J Bone Miner Res 25(12):2543-2552.
31. Tahimic CG, Wang Y, Bikle DD (2013) Anabolic effects of IGF-1 signaling on the skeleton. Front Endocrinol (Lausanne) 4:6.
32. Fulzele K, Clemens TL (2012) Novel functions for insulin in bone. Bone 50(2):452-456.
33. Yakar S, et al. (2002) Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110(6):771-781.
34. Wang Y, et al. (2011) IGF-1R signaling in chondrocytes modulates growth plate development by interacting with the PTHrP/Ihh pathway. J Bone Miner Res 26(7):1437-1446.
35. Wang Y, et al. (2007) IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J Bone Miner Res 22(9):1329-1337.
36. Fulzele K, et al. (2007) Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J Biol Chem 282(35):25649-25658.
37. Wang Y, et al. (2006) Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res 21(9):1350-1358.
38. Jilka RL (2013) The relevance of mouse models for investigating age-related bone loss in humans. J Gerontol A Biol Sci Med Sci 68(10):1209-1217.
39. Juul A, et al. (1995) Serum levels of insulin-like growth factor (IGF)-binding protein-3(IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80(8):2534-2542.
40. Takahashi Y (2012) Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver. Endocr J 59(11):955-962.
41. Zhang R, Lahens NF, Ballance HI, Hughes ME, Hogenesch JB (2014) A circadian gene expression atlas in mammals: Implications for biology and medicine. Proc Natl Acad Sci USA 111(45):16219-16224.
42. Klöting N, et al. (2008) Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes 57(8):2074-2082.
43. Schieber AM, et al. (2015) Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling. Science 350(6260):558-563.
44. Hamrick MW (2012) The skeletal muscle secretome: An emerging player in musclebone crosstalk. Bonekey Rep 1:60.
45. Banu J, Wang L, Kalu DN (2003) Effects of increased muscle mass on bone in male mice overexpressing IGF-I in skeletal muscles. Calcif Tissue Int 73(2):196-201.
46. Alzghoul MB, Gerrard D, Watkins BA, Hannon K (2004) Ectopic expression of IGF-I and Shh by skeletal muscle inhibits disuse-mediated skeletal muscle atrophy and bone osteopenia in vivo. FASEB J 18(1):221-223.
47. Wang Y, Bikle DD, Chang W (2013) Autocrine and Paracrine Actions of IGF-I Signaling in Skeletal Development. Bone Res 1(3):249-259.
48. Hamrick B (2012) RSO interview with Barbara Hamrick. Interview with a radiation safety officer. Health Phys 103(2, Suppl 2):S121-S123.
49. Lee SH, Kim TS, Choi Y, Lorenzo J (2008) Osteoimmunology: Cytokines and the skeletal system. BMB Rep 41(7):495-510.
50. Jones D, Glimcher LH, Aliprantis AO (2011) Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection. J Clin Invest 121(7):2534-2542.
51. Macpherson AJ, Harris NL (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4(6):478-485.
52. den Besten G, et al. (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54(9):2325-2340.
53. Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 125(6):1401-1412.
54. Stewart ML, Savarino V, Slavin JL (2009) Assessment of dietary fiber fermentation: Effect of Lactobacillus reuteri and reproducibility of short-chain fatty acid concentrations. Mol Nutr Food Res 53(Suppl 1):S114-S120.
55. Cox LM, et al. (2014) Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158(4):705-721.
56. Ashpole NM, et al. (2016) IGF-1 regulates vertebral bone aging through sex-specific and time-dependent mechanisms. J Bone Miner Res 31(2):443-454.
57. Steves CJ, Bird S, Williams FM, Spector TD (2016) The microbiome and musculoskeletal conditions of aging: A review of evidence for impact and potential therapeutics. J Bone Miner Res 31(2):261-269.
58. Cui Y, et al. (2011) Lrp5 functions in bone to regulate bone mass. Nat Med 17(6):684-691.
59. Chabbi-Achengli Y, et al. (2012) Decreased osteoclastogenesis in serotonin-deficient mice. Proc Natl Acad Sci USA 109(7):2567-2572.
60. Brommage R, et al. (2015) Adult Tph2 knockout mice without brain serotonin have moderately elevated spine trabecular bone but moderately low cortical bone thickness. Bonekey Rep 4:718.
61. Ciucci T, et al. (2015) Bone marrow Th17 TNFα cells induce osteoclast differentiation, and link bone destruction to IBD. Gut 64(7):1072-1081.
62. Li Y, Terauchi M, Vikulina T, Roser-Page S, Weitzmann MN (2014) B cell production of both OPG and RANKL is significantly increased in aged mice. Open Bone J 6:8-17.
63. Wesemann DR (2015) Microbes and B cell development. Adv Immunol 125:155-178.
64. Dempster DW, et al. (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. 28(1):2-17.